pancreatitis with glp 1 Frontiers american diabetes association pancreatitis history
Description
No injections needed just a daily tablet
In November 2025, the Trump administration announced landmark agreements with Eli Lilly and Novo Nordisk reducing the monthly price of GLP-1 weight-loss drugs from over $1,000 to as low as $245 for eligible patients
Stay on Track
The unchanged US$9.88 fair value estimate for LifeMD keeps the core price target steady, even as model inputs see only marginal tweaks
What went wrong?
